Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Accuray (ARAY) one of those stocks right now? A quick glance at the company's ...
In a report released yesterday, Neil Chatterji from B.Riley Financial reiterated a Buy rating on Accuray (ARAY – Research Report), with a price target of $7.50. The company’s shares closed yesterday ...
Roth MKM analyst Jason Wittes assigned a Buy rating to Accuray (ARAY – Research Report) today and set a price target of $7.00. The company’s shares closed yesterday at $1.43. Wittes covers the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback